within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AB25_Flumazenil;

model Flumazenil
  extends Pharmacolibrary.Drugs.ATC.V.V03AB25;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V03AB25</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Flumazenil is an imidazobenzodiazepine derivative used as a selective benzodiazepine receptor antagonist. It is primarily used for the reversal of benzodiazepine sedation during anesthesia and for the management of benzodiazepine overdose. Flumazenil is approved for clinical use and acts rapidly to counteract the central effects of benzodiazepines.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data reported for healthy adult volunteers following intravenous administration of flumazenil.</p><h4>References</h4><ol><li><p>Olkkola, KT, &amp; Ahonen, J (2008). Midazolam and other benzodiazepines. <i>Handbook of experimental pharmacology</i> None(182) 335–360. DOI:<a href=&quot;https://doi.org/10.1007/978-3-540-74806-9_16&quot;>10.1007/978-3-540-74806-9_16</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18175099/&quot;>https://pubmed.ncbi.nlm.nih.gov/18175099</a></p></li><li><p>Kilpatrick, GJ (2021). Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. <i>Frontiers in pharmacology</i> 12 690875–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2021.690875&quot;>10.3389/fphar.2021.690875</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34354587/&quot;>https://pubmed.ncbi.nlm.nih.gov/34354587</a></p></li><li><p>Nordt, SP, &amp; Clark, RF (1997). Midazolam: a review of therapeutic uses and toxicity. <i>The Journal of emergency medicine</i> 15(3) 357–365. DOI:<a href=&quot;https://doi.org/10.1016/s0736-4679(97)00022-x&quot;>10.1016/s0736-4679(97)00022-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9258787/&quot;>https://pubmed.ncbi.nlm.nih.gov/9258787</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Flumazenil;
